NUVB
NUVB
Indizes, Rohstoffe, Movers, Heatmap und Top-Stories. Ohne Login.
NUVB
NUVB NYSE
Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026
Nuvation Bio Inc. (NYSE:NUVB) Stock Rated “Moderate Buy” by Wall Street Analysts
Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer
Nuvation Bio Inc. (NUVB) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI® (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer
Nuvation Bio Inc. (NUVB) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
Umsatz & Nettogewinn (5J)
EPS & Wachstum (5J)
Free Cash Flow (5J)
Kapitalrendite
Operating- & Nettomarge (5J)
CapEx vs. Free Cashflow (5J)
Kapitalallokation (5J)
F&E- und SG&A-Intensität (5J)
EBITDA (5J)
Umsatzkosten (5J)
Marktkapitalisierung (5J)
Frag Blinx mit professionellen Marktdaten, Charts neben dem Chat und deinem Depot-Kontext.
Standard sind Lang & Schwarz Kurse. NASDAQ ist der verzögerte Listing-Kurs. Charts bleiben Tageskurse. Keine Anlageberatung.